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ter Carotid Stenting
Hans Tulip, David E. Timaran, Eric B. Rosero, Adriana J. Higuera,
R. James Valentine, Carlos H. Timaran University of Texas Southwestern
Med Ctr, Dallas, Tex
Background: Previous studies have investigated the development of
new ischemic brain lesions on diffusion-weighted MRI (DW-MRI) after
carotid artery stenting (CAS) for symptomatic stenosis. The rate of ischemic
brain injury after CAS for asymptomatic stenosis has not been established,
but is presumed to be less likely. This study assessed the occurrence of
cerebral embolization after CAS for asymptomatic vs symptomatic carotid
stenosis.
Methods: During an 18-month period, 40 patients undergoing CAS
under filter embolic protection were prospectively evaluated. Transcranial
Doppler (TCD) during CAS and pre- and 24-hour postprocedural DW-
MRI were used to assess cerebral embolization. Univariate and nonparamet-
ric analyses were used to compare differences in cerebral embolization after
CAS in asymptomatic and symptomatic patients.
Results: CAS was performed for 23 (58%) asymptomatic and 17
(42%) symptomatic carotid stenoses. The median microembolic counts
detected by TCD were 285 (interquartile range [IQR], 182-376) for
asymptomatic and 313 (IQR, 170-426) for symptomatic carotid stenosis
(P.6). New acute cerebral emboli detected with DW-MRI occurred in
50% of asymptomatic and 50% of symptomatic patients undergoing CAS
(P  .9). The ipsilateral and total median number of DW-MRI lesions
between groups were not statistically significantly different, i.e. 1 (IQR,
0-2.5) and 1.5 (IQR, 0-3) vs 0.5 (IQR, 0-2) and 0.5 (IQR, 0-3) for
asymptomatic vs symptomatic carotid stenosis, respectively (P .5). One
asymptomatic patient sustained a minor stroke after CAS, whereas no
new neurologic events occurred in symptomatic patients; the 30-day
stroke-death rate was 2.5% in this series.
Conclusions: Cerebral embolization, as detected by TCD and DW-
MRI, occurs with similar frequency after CAS for asymptomatic and
symptomatic carotid stenosis. This observational study questions the
safety of CAS under embolic protection for asymptomatic carotid steno-
sis as new ischemic brain injury occurs in approximately half of these
procedures.
Contralateral Occlusion is not a Clinically Important Reason for
Choosing Carotid Artery Stenting for Patients with Significant Carotid
Artery Stenosis
Luke P. Brewster, Karthik P. Kasirajan, Robert Beaulieu, James P. Reeves,
Matthew A. Corriere, Ravi Rajani, Ravi K. Veeraswamy, Atef K. Salam,
Thomas F. Dodson, Joseph J. Ricotta, Emory University Hospital, Atlanta, Ga
Introduction: Patients with internal carotid artery occlusion contralat-
eral to a diseased carotid artery are at an increased risk of stroke. It is our
practice to offer carotid intervention to symptomatic patients and patients
with severe ipsilateral carotid stenosis and contralateral occlusion. Both carotid
endarterectomy (CEA) and carotid artery stenting (CAS) are acceptable modes
of therapy. Contralateral carotid occlusion has been suggested as an indication
for CAS because of the theoretical advantages of reduced ischemic procedural
time and the lack of need for a vascular shunt or the assistance of general
anesthesia. However, CEA can also be done safely in this population and has
Fig 2.been associated with a decreased procedural stroke rate. Thus, it is not clear if
contralateral occlusion by itself is an appropriate indication to prefer CAS over
a
(EA. Here we compare our institution’s perioperative and one-year follow up
xperience with both CEA and CAS for patients with severe carotid artery
tenosis and contralateral internal carotid artery occlusion.
Methods: This is a retrospective review of our institution’s collective
onsecutive patient experience with CAS and CEA from 2/2007-7/2011.
hoice of therapy was determined by operator preference among vascular
urgery, cardiology, and interventional radiology, and the data collection
as performed using our computerized patient record after approval from
he Institutional Review Board. Patients were considered for review when
reated for carotid artery stenosis with contralateral carotid occlusion.
Results:Out of a total of 713 patients treated for carotid artery stenosis
uring this time period, 60 had contralateral occlusion. 40 of these patients
ere treated with CAS, and 20 with CEA. The most common indication for
AS were prior neck surgery (18), contralateral carotid occlusion alone (9),
nd prior neck radiation (7). The average age was 69.8 (/ 8.1) for CEA
nd 67.2 (/8.7) for CAS. There was a male bias in both groups (CEA
3/20; CAS 29/40; P.56), and both groups had similar amount of
ymptomatic patients (CEA 10/20, CAS 19/40). Two patients died within
0 days in the CAS group (5%) and no deaths occurred within 30 days in the
EA group. No perioperative strokes or myocardial infarction occurred in
ither group. One transient ischemic attack occurred after CAS. At mean
ollow up of 28/ 16 months (CEA) and 28/15 months (CAS)
range 1.5-48.5 months), 7 deaths occurred in the CAS group and two in
he CEA group (17.5% vs 10%, P  .7). There were no reoperations in the
EA group and one intervention in the CAS group for in-stent stenosis.
Conclusion: Although CEA and CAS can both be performed with
ood perioperative and midterm results, we find no reason to prefer CEA
ver CAS in patients whose only reason for consideration of CAS is con-
ralateral occlusion.
arly Versus Delayed Carotid Endarterectomy for Symptomatic Ca-
otid Stenosis: A Single-Institution Experience
uman Annambhotla, Michael S. Park, Mark L. Keldahl, Mark D. Morasch,
eron E. Rodriguez, William H. Pearce, Melina R. Kibbe,
ark K. Eskandari, Northwestern University, Chicago, Ill
Introduction: Delayed carotid endarterectomy (CEA) after a recent
troke or transient ischemic attack (TIA) is associated with risks of recurrent
eurologic symptoms. In an effort to preserve cerebral function, urgent early
EA has been recommended in some instances.
Methods: Retrospective chart review from a single university hospital
ertiary care center between November 1998 and February 2011 revealed
09 patients who underwent CEA following stroke or TIA. Of these 309
atients, 87 received their CEA within 30 days of symptom onset and 222
eceived their CEA after 30 days from symptomonset. The early CEA cohort
as further stratified according to the timing of surgery: Group A (33
atients), within 7 days; Group B (21), between 8 and 14 days; Group C
17), between 15 and 21 days; and Group D (15), between 22 and 30 days.
emographic data as well as 30-day (mortality, stroke, TIA, and myocardial
nfarction) and long-term (all-cause mortality and stroke) rates were ana-
yzed for each Group. These were also analyzed for the entire early CEA
ohort and compared against the delayed CEA cohort.
Results: Demographics and co-morbid conditions were similar be-
ween groups. For 30-day outcomes, there were no deaths (0%), two strokes
2.4%), two TIAs (2.4%), and two myocardial infarctions (2.4%) in the early
EA cohort; in the delayed CEA cohort, there were 4 (1.8%), 4 (1.8%), 3
1.4%), and 3 (1.4%) patients with these outcomes, respectively (P  0.05
or all comparisons). Over the long-term, the early group had one ipsilateral
troke at 17 months and the delayed group had two ipsilateral strokes at 3
nd 12 months. For long-term outcomes, there were 21 deaths in the early
EA cohort (24.4%) and 67 deaths in the delayed CEA cohort (30.2%, P
05). Mean follow-up times were 4.5 years in the early CEA cohort and 5.8
ears in the delayed CEA cohort.
Conclusions: There were no differences in 30-day and long-term
dverse outcome rates between the early and delayed CEA cohorts. Early
EA is preferred in carefully selected patients following a TIA or non-
isabling stroke over delayed CEA.
obotic Thoracoscopic First Rib Resection and Scalenectomy for
reatment of Pagett-Schroetter Syndrome
ichard F. Neville1, Farid Gharagozloo2,MarkMeyer3, Barbara Tempesta2,
rini Tummala4 1George Washington University, Washington, DC; 2Wash-
ngton Institute of Thoracic and Cardiovascular Surgery, Washington, DC;
Institute of Thoracic and Cardiovascular Surgery, Washington, DC; 4Res-
on Radiology Consultants, Reston Hospital, Reston, Va
Objectives: First rib resection is a key component of the treatment for
xillo-subclavian venous thrombosis due to thoracic outlet compression
Paget-Schroetter syndrome). Previously described techniques, transaxillary
